Use of the PRIME-MD Patient Health Questionnaire for estimating the prevalence of psychiatric disorders in French primary care: comparison with family practitioner estimates and relationship to psychotropic medication use

General Hospital Psychiatry

Volumn 29, Issue 4, 2007, Pages 285-293

  Norton, Joanna ^a   De Roquefeuil, Guilhem ^a   Boulenger, Jean Philippe ^a,b   Ritchie, Karen ^a   Mann, Anthony ^a,c   Tylee, Andre ^c  

^a Montpellier 1 University   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Case recognition; Family practitioner; Patient Health Questionnaire

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; FRANCE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PANIC; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; SOMATOFORM DISORDER;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 34250858928     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2007.02.005     Document Type: Article

References (50)

1. Alonso J., Angermeyer M.C., Bernert S., et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420 (2004) 55-64
2. Gasquet I., Nègre-Pagès L., Fourrier A., et al. Usage des psychotropes et troubles psychiatriques en France: résultats de l'étude épidémiologique ESEMeM/MHEDEA 2000/ (ESEMeD) en population générale. Encephale 31 (2005) 195-206
3. Ohayon M.M., and Lader M.H. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 63 9 (2002) 817-825
4. Tylee A., Gastpar M., Lepine J.P., and Mendlewicz J. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol 14 3 (1999) 139-151
5. Lecadet J., Vidal P., Baris B., et al. Médicaments psychotropes: consommation et pratiques de prescription en France métropolitaine II. Données et comparaisons régionales, 2000. Rev Med Assur Mal 34 4 (2003)
6. Olié J.P., El Omari F., Spadone C., and Lepine J.P. Résultats d'une enquête sur l'usage des antidépresseurs en population générale française. Encephale 23 Cahier 1 (2002) 411-417
7. Baumann M, Alla F, Empereur F. Psychotropes et dépendances: profil des consommateurs et trajectoires de leurs comportements. Observatoire Français des Drogues et des Toxicomanies; mai (2001).
8. Lecrubier Y., Boyer P., Lepine J.P., and Weiller E. Results from the Paris centre. vol. ed. In: Ustun T.B., and Sartorius N. (Eds). Mental illness in general health care: an international study (1995), John Wiley and sons Ltd, Chichester 211-225
9. Goldberg D.P., and Williams P. A user's guide to the General Health Questionnaire. Vol. ed. (1988), NFER-NELSON, Windsor
10. WHO. The ICD-10 classification of mental and behavioral disorders - diagnostic criteria for research. Vol. ed. (1993), WHO, Geneva
11. Norton J., De Roquefeuil G., Benjamins A., Boulenger J.P., and Mann A. Psychiatric morbidity, disability and service use amongst primary care attenders in France. Eur Psychiatry 19 (2004) 164-167
12. Spitzer R.L., Kroenke K., and Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 282 18 (1999) 1737-1744
13. Diagnostic and Statistical Manual of Psychiatric Disorders. Vol. ed. (1994), American Psychiatric Association, Washington (DC)
14. Spitzer R.L., Williams J.B., Kroenke K., et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 Study. JAMA 272 22 (1994) 1749-1756
15. Spitzer R.L., Williams J.B., Kroenke K., Hornyak R., and McMurray J. Validity and utility of the PRIME-MD Patient Health Questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 183 3 (2000) 759-769
16. Lowe B., Grafe K., Zipfel S., et al. Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom 73 6 (2004) 386-390
17. Lowe B., Schenkel I., Bair M.J., and Gobel C. Efficacy, predictors of therapy response, and safety of sertraline in routine clinical practice: prospective, open-label, non-interventional postmarketing surveillance study in 1878 patients. J Affect Disord 87 2-3 (2005) 271-279
18. Lowe B., Spitzer R.L., Grafe K., et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 78 2 (2004) 131-140
19. Lowe B., Grafe K., Zipfel S., et al. Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis. J Psychosom Res 55 6 (2003) 515-519
20. Ansseau M., Dierick M., Buntinkx F., et al. High prevalence of mental disorders in primary care. J Affect Disord 78 (2004) 49-55
21. Persoons P., Luyckx K., Desloovere C., Vandenberghe J., and Fischler B. Anxiety and mood disorders in otorhinolaryngology outpatients presenting with dizziness: validation of the self-administered PRIME-MD Patient Health Questionnaire and epidemiology. Gen Hosp Psychiatry 25 5 (2003) 316-323
22. Rief W., Nanke A., Klaiberg A., and Braehler E. Base rates for panic and depression according to the Brief Patient Health Questionnaire: a population-based study. J Affect Disord 82 (2004) 271-276
23. INSEE. Circonscriptions législatives: résultats du recensement de la population de mars 1999 (1999). http://www.recensement.insee/RP99/ Available at:
24. Darrine S, Niel X. Les médecins omnipraticiens au 1er janvier 2000. DREES: Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques - Etudes et Résultats. janvier 2001;No 99.
25. Von Korff M., and Ustün T.B. Methods of the WHO collaborative study on 'Psychological Problems in General Health Care'. In: Ustün T.B., and Sartorius N. (Eds). Mental illness in general health care. An international study Vol. ed. (1995), John Wiley and Sons 19-38
26. Beecham J., and Knapp M. Costing psychiatric interventions. In: Thornicroft G., Brewin C., and Wing J. (Eds). Measuring mental health needs Vol. ed. (1992), Gaskell, London 163-183
27. ETAP®. Evaluation des Troubles Affectifs par le Clinicien, Version Française du PRIME-MD, Pfizer Inc (1994)
28. http://www.theriaque.org. Centre National hospitalier d'information sur le médicament 2002. In: eds. trans. Vol. ed.
29. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 20 (1960) 37-46
30. Templeton L., Deehan A., Taylor C., Drummond C., and Strang J. Surveying general practitioners: does a low response rate matter?. Br J Gen Pract 47 415 (1997) 91-94
31. Deehan A., Templeton L., Taylor C., Drummond C., and Strang J. The effect of cash and other financial inducements on the response rate of general practitioners in a national postal study. Br J Gen Pract 47 415 (1997) 87-90
32. Freeman G.K., Horder J.P., Howie J.G., et al. Evolving general practice consultation in Britain: issues of length and context. BMJ 324 7342 (2002) 880-882
33. Farrell M., Howes S., Bebbington P., et al. Nicotine, alcohol and drug dependence, and psychiatric comorbidity - results of a national household survey. Int Rev Psychiatry 15 1-2 (2003) 50-56
34. Bijl R.V., Ravelli A., and van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 33 12 (1998) 587-595
35. Rehm J., Room R., Monteiro M., et al. Alcohol. In: Ezzati M., Lopez A.D., Rodgers A., and Murray C. (Eds). Comparative quantification of health risks: global and regional burden of disease due to selected major risk factors Vol. ed. (2004), WHO, Geneva
36. Mouquet M.C., and Villet H. Les risques d'alcoolisation excessive chez les patients ayant recours aux soins un jour donné. DREES - Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques. Etudes et Résultats. Septembre 192 (2002)
37. Wutzke S.E., Conigrave K.M., Saunders J.B., and Hall W.D. The long-term effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up. Addiction 97 6 (2002) 665-675
38. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51 1 (1994) 8-19
39. Simon G., and Von Korff M. Results from the Seattle centre. In: Ustun T.B., and Sartorius N. (Eds). Mental illness in general health care: an international study Vol. ed. (1995), John Wiley and sons Ltd, Chichester 265-284
40. M. Briot, Rapport sur le bon usage des médicaments psychotropes. Office Parlementaire d'Evaluation des Politiques de Santé (OPEPS); 22 juin (2006).
41. Gerber P.D., Barrett J., Barrett J., et al. Recognition of depression by internists in primary care: a comparison of internist and "gold standard" psychiatric assessments. J Gen Intern Med 4 1 (1989) 7-13
42. Ormel J., Van Den Brink W., Koeter M.W., et al. Recognition, management and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychol Med 20 4 (1990) 909-923
43. Von Korff M., Shapiro S., Burke D., et al. Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. Arch Gen Psychiatry 44 2 (1987) 152-156
44. Coyne J.C., Schwenk T.L., and Fechner-Bates S. Nondetection of depression by primary care physicians reconsidered. Gen Hosp Psychiatry 17 1 (1995) 3-12
45. Linden M., Lecrubier Y., Bellantuono C., et al. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 19 2 (1999) 132-140
46. Hull S.A., Aquino P., and Cotter S. Explaining variation in antidepressant prescribing rates in east London: a cross sectional study. Fam Pract 22 1 (2005) 37-42
47. Berardi D., Menchetti M., Cevenini N., et al. Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression. Psychother Psychosom 74 4 (2005) 225-230
48. Kisely S., Linden M., Bellantuono C., Simon G., and Jones J. Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study. Psychol Med 30 5 (2000) 1217-1225
49. Wittchen H.U., Hofler M., and Meister W. Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated?. Int Clin Psychopharmacol 16 3 (2001) 121-135
50. Kuhn F., Pédaillès S., Pull M.T., Guyon F.X., and Thielly P. Adéquation à l'autorisation de mise sur le marché des instaurations de traitement par inhibiteurs spécifiques de la récapture de la sérotonine. Rev Med Assur Mal 37 1 (2006) 1-7 janvier-mars